Edgar Specker

Design, Quality and Validation of the EU-OPENSCREEN Fragment Library Poised to a High-Throughput Screening Collection

• Xavier Jalencas; Hannes Berg; Ludvik Olai Espeland; Sridhar Sreeramulu; Franziska Kinnen; Christian Richter; Charis Georgiou; Vladyslav Yadrykhinsky; Edgar Specker; Kristaps Jaudzems; Tanja Miletić; Robert Harmel; Phil Gribbon; Harald Schwalbe; Ruth Brenk; Aigars Jirgensons; Andrea Zaliani; Jordi Mestres

RSC Medicinal Chemistry 2024

Structure-Based Design of Xanthine-Benzimidazole Derivatives as Novel and Potent Tryptophan Hydroxylase Inhibitors

• Edgar Specker; Susann Matthes; Radoslaw Wesolowski; Anja Schütz; Maik Grohmann; Natalia Alenina; Dirk Pleimes; Keven Mallow; Martin Neuenschwander; Angelina Gogolin; Marie Weise; Jochen Pfeifer; Nandor Ziebart; Udo Heinemann; Jens Peter von Kries; Marc Nazaré; Michael Bader

Journal of Medicinal Chemistry 2022

Probing Factor Xa Protein–Ligand Interactions: Accurate Free Energy Calculations and Experimental Validations of Two Series of High-Affinity Ligands

• María Isabel Fernández-Bachiller; Songhwan Hwang; María Elena Schembri; Peter Lindemann; Mónica Guberman; Svenja Herziger; Edgar Specker; Hans Matter; David W. Will; Jörg Czech; Michael Wagner; Armin Bauer; Herman Schreuder; Kurt Ritter; Matthias Urmann; Volkmar Wehner; Han Sun; Marc Nazaré

Journal of Medicinal Chemistry 2022

Topical inflammasome inhibition with disulfiram prevents irritant contact dermatitis

• Hanna Bonnekoh; Carolina Vera; Angela Abad‐Perez; Silke Radetzki; Martin Neuenschwander; Edgar Specker; Niklas Amadeus Mahnke; Stefan Frischbutter; Eicke Latz; Marc Nazaré; Jens v. Kries; Marcus Maurer; Jörg Scheffel; Karoline Krause

Clinical and Translational Allergy 2021

Enhanced Properties of a Benzimidazole Benzylpyrazole Lysine Demethylase Inhibitor: Mechanism-of-Action, Binding Site Analysis, and Activity in Cellular Models of Prostate Cancer

• David M. Carter; Edgar Specker; Piotr H. Małecki; Jessica Przygodda; Krystyna Dudaniec; Manfred S. Weiss; Udo Heinemann; Marc Nazare; Ulrich Gohlke

Journal of Medicinal Chemistry 2021

NMR quality control of fragment libraries for screening

• Sreeramulu, Sridhar; Richter, Christian; Kuehn, Till; Azzaoui, Kamal; Blommers, Marcel Jules José; Conte, Rebecca Del; Fragai, Marco; Trieloff, Nils; Schmieder, Peter; Nazaré, Marc; Specker, Edgar; Ivanov, Vladimir; Oschkinat, Hartmut; Banci, Lucia; Schwalbe, Harald

Journal of biomolecular NMR 2020

Small-Molecule Lysophosphatidic Acid Receptor 5 (LPAR5) Antagonists: Versatile Pharmacological Tools to Regulate Inflammatory Signaling in BV-2 Microglia Cells

• Ioanna Plastira; Lisha Joshi; Eva Bernhart; Jens Schoene; Edgar Specker; Marc Nazare; Wolfgang Sattler

Frontiers in Cellular Neuroscience 2019

EU-OPENSCREEN: A Novel Collaborative Approach to Facilitate Chemical Biology

• Philip Brennecke; Dace Rasina; Oscar Aubi; Katja Herzog; Johannes Landskron; Bastien Cautain; Francisca Vicente; Jordi Quintana; Jordi Mestres; Bahne Stechmann; Bernhard Ellinger; Jose Brea; Jacek L. Kolanowski; Radosław Pilarski; Mar Orzaez; Antonio Pineda-Lucena; Luca Laraia; Faranak Nami; Piotr Zielenkiewicz; Kamil Paruch; Espen Holst Hansen; Jens P. von Kries; Martin Neuenschwander; Edgar Specker; Petr Bartunek; Sarka Simova; Zbigniew Leśnikowski; Stefan Krauss; Lari Lehtiö; Ursula Bilitewski; Mark Brönstrup; Kjetil Taskén; Aigars Jirgensons; Heiko Lickert; Mads H. Clausen; Jeanette H. Andersen; Maria J. Vicent; Olga Genilloud; Aurora Martinez; Marc Nazaré; Wolfgang Fecke; Philip Gribbon

SLAS Discovery 2019

A New Highly Thyrotropin Receptor-Selective Small-Molecule Antagonist with Potential for the Treatment of Graves' Orbitopathy

• Patrick Marcinkowski; Inna Hoyer; Edgar Specker; Jens Furkert; Claudia Rutz; Martin Neuenschwander; Sebastian Sobottka; Han Sun; Marc Nazare; Utta Berchner-Pfannschmidt; Jens Peter von Kries; Anja Eckstein; Ralf Schülein; Gerd Krause

Thyroid 2019

Use of a sequential high throughput screening assay to identify novel inhibitors of the eukaryotic SRP-Sec61 targeting/translocation pathway

• Wolfgang Klein; Claudia Rutz; Jamina Eckhard; Becky Provinciael; Edgar Specker; Martin Neuenschwander; Gunnar Kleinau; Patrick Scheerer; Jens-Peter von Kries; Marc Nazaré; Kurt Vermeire; Ralf Schülein

PLOS ONE 2018

CellFy: A Cell-Based Fragment Screen against C-Type Lectins

• Jessica Schulze; Hannes Baukmann; Robert Wawrzinek; Felix F. Fuchsberger; Edgar Specker; Jonas Aretz; Marc Nazare; Christoph Rademacher

ACS Chemical Biology 2018

A Small-Molecule Antagonist of the β-Catenin/TCF4 Interaction Blocks the Self-Renewal of Cancer Stem Cells and Suppresses Tumorigenesis

• Liang Fang; Qionghua Zhu; Martin Neuenschwander; Edgar Specker; Annika Wulf-Goldenberg; William I. Weis; Jens P. von Kries; Walter Birchmeier

Cancer Research 2016

Temperature dependence of cross-effect dynamic nuclear polarization in rotating solids: advantages of elevated temperatures

• Michel-Andreas Geiger; Marcella Orwick-Rydmark; Katharina Märker; W. Trent Franks; Dmitry Akhmetzyanov; Daniel Stöppler; Maximilian Zinke; Edgar Specker; Marc Nazaré; Anne Diehl; Barth-Jan van Rossum; Fabien Aussenac; Thomas Prisner; Ümit Akbey; Hartmut Oschkinat

Physical Chemistry Chemical Physics 2016

Design of a General‐Purpose European Compound Screening Library for EU‐OPENSCREEN

• Dragos Horvath; Michael Lisurek; Bernd Rupp; Ronald Kühne; Edgar Specker; Jens von Kries; Didier Rognan; C. David Andersson; Fredrik Almqvist; Mikael Elofsson; Per‐Anders Enqvist; Anna‐Lena Gustavsson; Nikita Remez; Jordi Mestres; Gilles Marcou; Alexander Varnek; Marcel Hibert; Jordi Quintana; Ronald Frank

ChemMedChem 2014

Tractable synthesis of multipurpose screening compounds with under-represented molecular features for an open access screening platform

• Felix Wilde; Edgar Specker; Martin Neuenschwander; Marc Nazaré; Anja Bodtke; Andreas Link

Molecular Diversity 2014

Determination of glucan phosphorylation using heteronuclear ¹H,¹³C double and ¹H,¹³C,³¹P triple‐resonance NMR spectra

• Peter Schmieder; Felix Nitschke; Martin Steup; Keven Mallow; Edgar Specker

Magnetic Resonance in Chemistry 2013

Sustainable synthesis and automated deposition: an accessible discovery screening library of fragment-like purines

• Christoph Kamper; Katharina Korpis; Edgar Specker; Lennart Anger; Martin Neuenschwander; Patrick J. Bednarski; Andreas Link

Molecular Diversity 2012

Neurotoxin II Bound to Acetylcholine Receptors in Native Membranes Studied by Dynamic Nuclear Polarization NMR

• Arne H. Linden; Sascha Lange; W. Trent Franks; Ümit Akbey; Edgar Specker; Barth-Jan van Rossum; Hartmut Oschkinat

Journal of the American Chemical Society 2011

Aspartic Acid Proteases as Therapeutic Targets. Edited by Arun K. Ghosh.

• Edgar Specker

ChemMedChem 2011

A highly sensitive fluorometric assay for determination of human coagulation factor XIII in plasma

• Kai Oertel; Andreas Hunfeld; Edgar Specker; Christine Reiff; Rainer Seitz; Ralf Pasternack; Johannes Dodt

Analytical Biochemistry 2007

Unexpected Novel Binding Mode of Pyrrolidine‐Based Aspartyl Protease Inhibitors: Design, Synthesis and Crystal Structure in Complex with HIV Protease

• Edgar Specker; Jark Böttcher; Sascha Brass; Andreas Heine; Hauke Lilie; Andreas Schoop; Gerhard Müller; Nils Griebenow; Gerhard Klebe

ChemMedChem 2006

De-novo-Design und Synthese neuer Leitstrukturen als Übergangszustandsmimetika zur selektiven Inhibition der HIV-1-Protease und Cathepsin D

• Edgar Specker